ImageneBio, Inc.
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,687.5% | -3,310.9% | – | – | -255.4% | – | -1,320.3% | – | – | – | – | – | – | |
| 20.4% | 46.3% | – | – | 2.6% | – | 10.9% | – | – | – | – | – | – | |
| 168.6% | 266.3% | – | – | 29.1% | – | 113.0% | – | – | – | – | – | – | |
| -404.1% | -968.4% | – | – | -1.8% | – | -408.9% | – | – | – | – | – | – | |
| 0.0% | 39.8% | – | – | 0.0% | – | 0.0% | – | – | – | – | – | – | |
| 2,691.5% | 3,092.0% | – | – | 270.1% | – | 991.5% | – | – | – | – | – | – | |
| – | 16.4% | – | – | – | – | – | – | – | – | – | – | – | |
| 3,284.2% | 9.1% | – | – | – | – | 3.4% | – | – | – | – | – | – | |
| 4,288.2% | -209.9% | – | – | 14.7% | – | -328.8% | – | – | – | – | – | – | |
| -1,687.5% | -3,350.7% | – | – | -255.4% | – | -1,320.3% | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.